{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:22:32Z","timestamp":1789842152298,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-009"],"award-info":[{"award-number":["2022-PUMCH-B-009"]}]},{"name":"the National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-063"],"award-info":[{"award-number":["2022-PUMCH-A-063"]}]},{"name":"the third batch of social public welfare and basic research projects in Zhongshan City in 2021","award":["2021B3012"],"award-info":[{"award-number":["2021B3012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-023-04729-w","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T11:02:14Z","timestamp":1705057334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparisons of mpMRI, 68Ga-PSMA PET\/CT and mpMRI combined with 68Ga-PSMA PET\/CT in diagnosing prostate cancer based on tumor detection, localization and staging"],"prefix":"10.1007","volume":"42","author":[{"given":"Zhipeng","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhien","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runqiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weigang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"4729_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0090-4295(98)00278-7","volume":"52","author":"SD Sweat","year":"1998","unstructured":"Sweat SD, Pacelli A, Murphy GP, Bostwick DG (1998) Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology 52:637\u2013640","journal-title":"Urology"},{"key":"4729_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.eururo.2021.11.019","volume":"82","author":"VH Meissner","year":"2022","unstructured":"Meissner VH, Rauscher I, Schwamborn K, Neumann J, Miller G, Weber W et al (2022) Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol 82:156\u2013160","journal-title":"Eur Urol"},{"key":"4729_CR3","first-page":"58","volume":"18","author":"MH Gultekin","year":"2020","unstructured":"Gultekin MH, Demirci E, Turegun FA, Kabasakal L, Sahin OE, Ocak M et al (2020) The role of 68GA-PSMA PET\/CT scan in patients with prostate adenocarcinoma who underwent radical prostatectomy. Urol J 18:58\u201365","journal-title":"Urol J"},{"key":"4729_CR4","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.euf.2021.01.016","volume":"7","author":"V Murthy","year":"2021","unstructured":"Murthy V, Sonni I, Jariwala N, Juarez R, Reiter RE, Raman SS et al (2021) The role of PSMA PETCT and PETMRI in the initial staging of prostate cancer. Eur Urol Focus 7:258\u2013266","journal-title":"Eur Urol Focus"},{"key":"4729_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109131","volume":"130","author":"R Wang","year":"2020","unstructured":"Wang R, Shen G, Yang R, Ma X, Tian R (2020) 68Ga-PSMA PET\/MRI for the diagnosis of primary and biochemically recurrent prostate cancer: a meta-analysis. Eur J Radiol 130:109131","journal-title":"Eur J Radiol"},{"key":"4729_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.eururo.2018.08.009","volume":"75","author":"M L\u00f8vf","year":"2019","unstructured":"L\u00f8vf M, Zhao S, Axcrona U, Johannessen B, Bakken AC, Carm KT et al (2019) Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity. Eur Urol 75:498\u2013505","journal-title":"Eur Urol"},{"key":"4729_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pros.24091","volume":"81","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Mai Z, Yan W, Chen Y, Zhou Z, Xiao Y et al (2021) The characteristics and spatial distributions of prostate cancer in autopsy specimens. Prostate 81:135\u2013141","journal-title":"Prostate"},{"key":"4729_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.juro.2014.11.015","volume":"193","author":"M Valerio","year":"2015","unstructured":"Valerio M, Anele C, Freeman A, Jameson C, Singh PB, Hu Y et al (2015) Identifying the index lesion with template prostate mapping biopsies. J Urol 193:1185\u20131190","journal-title":"J Urol"},{"key":"4729_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41391-021-00485-3","volume":"25","author":"AYM Lee","year":"2022","unstructured":"Lee AYM, Chen K, Tan YG, Lee HJ, Shutchaidat V, Fook-Chong S et al (2022) Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis 25:720\u2013726","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4729_CR10","doi-asserted-by":"publisher","first-page":"730.e17","DOI":"10.1016\/j.urolonc.2021.04.021","volume":"39","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Zhou Y, Yan W, Sun H, Li Q, Li H et al (2021) Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRIUS fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer. Urol Oncol 39:730.e17\u201322","journal-title":"Urol Oncol"},{"key":"4729_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/bju.13977","volume":"121","author":"Z Mai","year":"2018","unstructured":"Mai Z, Xiao Y, Yan W, Zhou Y, Zhou Z, Liang Z et al (2018) Comparison of lesions detected and undetected by template-guided transperineal saturation prostate biopsy. BJU Int 121:415\u2013420","journal-title":"BJU Int"},{"key":"4729_CR12","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1007\/s00330-022-08625-6","volume":"32","author":"H Zheng","year":"2022","unstructured":"Zheng H, Miao Q, Liu Y, Mirak SA, Hosseiny M, Scalzo F et al (2022) Multiparametric MRI-based radiomics model to predict pelvic lymph node invasion for patients with prostate cancer. Eur Radiol 32:5688\u20135699","journal-title":"Eur Radiol"},{"key":"4729_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.117.198119","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M et al (2018) Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-Ligand PET\/CT. J Nucl Med 59:469\u2013478","journal-title":"J Nucl Med"},{"key":"4729_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/MOU.0000000000000537","volume":"28","author":"RR Tourinho-Barbosa","year":"2018","unstructured":"Tourinho-Barbosa RR, de la Rosette J, Sanchez-Salas R (2018) Prostate cancer multifocality, the index lesion, and the microenvironment. Curr Opin Urol 28:499\u2013505","journal-title":"Curr Opin Urol"},{"key":"4729_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/his.13712","volume":"74","author":"A Matoso","year":"2019","unstructured":"Matoso A, Epstein JI (2019) Defining clinically significant prostate cancer on the basis of pathological findings. Histopathology 74:135\u2013145","journal-title":"Histopathology"},{"key":"4729_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA et al (2016) The 2014 International Society of Urological Pathology(ISUP) consensus conference on gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244\u2013252","journal-title":"Am J Surg Pathol"},{"key":"4729_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","volume":"67","author":"JD Le","year":"2015","unstructured":"Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS et al (2015) Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol 67:569\u2013576","journal-title":"Eur Urol"},{"key":"4729_CR18","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","volume":"361","author":"HU Ahmed","year":"2009","unstructured":"Ahmed HU (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361:1704\u20131706","journal-title":"N Engl J Med"},{"key":"4729_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.eururo.2020.05.018","volume":"78","author":"AH Lebastchi","year":"2022","unstructured":"Lebastchi AH, George AK, Polascik TJ, Coleman J, de la Rosette J, Turkbey B et al (2022) Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international multidisciplinary consensus. Eur Urol 78:371\u2013378","journal-title":"Eur Urol"},{"key":"4729_CR20","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","volume":"74","author":"S Guillaumier","year":"2018","unstructured":"Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T et al (2018) A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer. Eur Urol 74:422\u2013442","journal-title":"Eur Urol"},{"key":"4729_CR21","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12885-018-5124-9","volume":"18","author":"Z Mai","year":"2018","unstructured":"Mai Z, Zhou Z, Yan W, Xiao Y, Zhou Y, Liang Z et al (2018) The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens. BMC Cancer 18:1205\u20131220","journal-title":"BMC Cancer"},{"key":"4729_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/jmri.25363","volume":"45","author":"SS Salami","year":"2017","unstructured":"Salami SS, Ben-Levi E, Yaskiv O, Turkbey B, Villani R, Rastinehad AR (2017) Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI. J Magn Reson Imaging 45:610\u2013616","journal-title":"J Magn Reson Imaging"},{"key":"4729_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bju.14858","volume":"126","author":"AA Kalapara","year":"2020","unstructured":"Kalapara AA, Nzenza T, Pan HYC, Ballok Z, Ramdave S, O\u2019Sullivan R et al (2020) Detection and localisation of primary prostate cancer using 68gallium prostate-specific membrane antigen positron emission tomography\/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology. BJU Int 126:83\u201390","journal-title":"BJU Int"},{"key":"4729_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41391-020-00270-8","volume":"24","author":"E Koseoglu","year":"2021","unstructured":"Koseoglu E, Kordan Y, Kilic M, Sal O, Seymen H, Kiremit MC et al (2021) Diagnostic ability of Ga-68PSMA PET to detect dominant and non-dominant tumors, upgrading and adverse pathology in patients with PIRADS 4\u20135 index lesions undergoing radical prostatectomy. Prostate Cancer Prostatic Dis 24:202\u2013209","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4729_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2967\/jnumed.120.245605","volume":"62","author":"S Klingenberg","year":"2021","unstructured":"Klingenberg S, Jochumsen MR, Ulh\u00f8i BP, Freds\u00f8e J, S\u00f8rensen KD, Borre M et al (2021) 68Ga-PSMA PET\/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer. J Nucl Med 62:214\u2013220","journal-title":"J Nucl Med"},{"key":"4729_CR26","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s00259-020-04718-w","volume":"47","author":"J Miksch","year":"2020","unstructured":"Miksch J, Bottke D, Krohn T, Thamm R, Bartkowiak D, Solbach C et al (2020) Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET\/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging 47:2339\u20132347","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4729_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/pros.24420","volume":"82","author":"T Ucar","year":"2022","unstructured":"Ucar T, Gunduz N, Demirci E, Culpan M, Gunel H, Kir G et al (2022) Comparison of 68Ga-PSMA PET\/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: a retrospective study. Prostate 82:1462\u20131468","journal-title":"Prostate"},{"key":"4729_CR28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1159\/000509974","volume":"104","author":"S \u00c7elen","year":"2020","unstructured":"\u00c7elen S, G\u00fcltekin A, \u00d6zl\u00fclerden Y, Mete A, Sa\u011fta\u015f E, Ufuk F et al (2020) Comparison of 68Ga-PSMA-I\/T PET-CT and multiparametric MRI for locoregional staging of prostate cancer patients: a pilot study. Urol Int 104:684\u2013691","journal-title":"Urol Int"},{"key":"4729_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2967\/jnumed.118.221010","volume":"60","author":"M Chen","year":"2019","unstructured":"Chen M, Zhang Q, Zhang C, Zhao X, Marra G, Gao J et al (2019) Combination of 68Ga-PSMA PET\/CT and multiparametric MRI improves the detection of clinically significant prostate cancer: a lesion-by-lesion analysis. J Nucl Med 60:944\u2013949","journal-title":"J Nucl Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04729-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04729-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04729-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:18:10Z","timestamp":1735852690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04729-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4729"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04729-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,12]]},"assertion":[{"value":"11 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our study was approved by the Ethics Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"29"}}